Major pathogenic mechanisms in vascular dementia: Roles of cellular stress response and hormesis in neuroprotection
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Vascular dementia (VaD), considered the second most common cause of cognitive impairment after Alzheimer disease in the elderly, involves the impairment of memory and cognitive function as a consequence of cerebrovascular disease. Chronic cerebral hypoperfusion is a common pathophysiological condition frequently occurring in VaD. It is generally associated with neurovascular degeneration, in which neuronal damage and blood‐brain barrier alterations coexist and evoke beta‐amyloid–induced oxidative and nitrosative stress, mitochondrial dysfunction, and inflammasome‐ promoted neuroinflammation, which contribute to and exacerbate the course of disease. Vascular cognitive impairment comprises a heterogeneous group of cognitive disorders of various severity and types that share a presumed vascular etiology. The present study reviews major pathogenic factors involved in VaD, highlighting the relevance of cerebrocellular stress and hormetic responses to neurovascular insult, and addresses these mechanisms as potentially viable and valuable as foci of novel neuroprotective methods to mitigate or prevent VaD. © 2016 Wiley Periodicals, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
How mitochondria produce reactive oxygen species
Murphy, M. P. (2009) · Biochemical Journal · doi:10.1042/bj20081386 · Cited by 8,207
A role for mitochondria in nlrp3 inflammasome activation
Zhou, R., Yazdi, A. S., Menu, P., & Tschopp, J. (2011) · Nature · doi:10.1038/nature09663 · Cited by 5,602
Neurovascular pathways to neurodegeneration in Alzheimer’s disease and other disorders
Zlokovic, B. V. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3114 · Cited by 2,969
NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice
Heneka, M. T., Kummer, M. P., Stutz, A., Delekate, A., Schwartz, S., Vieira-Saecker, A., Griep, A., Axt, D., Remus, A., Tzeng, T.-C., et al. (2013) · Nature · doi:10.1038/nature11729 · Cited by 2,898 · cited 2×
“In addition, a significant decrease in microglial accumulation was measured in the brain of Asc and Casp1 mice that were injected with fibrillar Ab (vs. wild-type mice; Heneka et al., 2013).”
BackgroundAdapting Proteostasis for Disease Intervention
Balch, W. E., Morimoto, R. I., Dillin, A., & Kelly, J. W. (2008) · Science · doi:10.1126/science.1141448 · Cited by 2,495 · cited 3×
“…the activation of prosurvival pathways, including production of molecules endowed with antioxidant and antiapoptotic activity, are controlled by cytoprotective genes, called vitagenes (Balch et al., 2008; Calabrese et al., 2007; Calabrese, 2008a; Calabrese et al., 2009; Calabrese et al., 2010).”
BackgroundThe NALP3 inflammasome is involved in the innate immune response to amyloid-β
Halle, A., Hornung, V., Petzold, G. C., Stewart, C. R., Monks, B. G., Reinheckel, T., Fitzgerald, K. A., Latz, E., Moore, K. J., & Golenbock, D. T. (2008) · Nature Immunology · doi:10.1038/ni.1636 · Cited by 2,441
Transcriptional paradigms in mammalian mitochondrial biogenesis and function
Scarpulla, R. C. (2008) · Physiological Reviews · doi:10.1152/physrev.00025.2007 · Cited by 1,666
Baumgart, M., Snyder, H. M., Carrillo, M. C., Fazio, S., Kim, H., & Johns, H. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2015.05.016 · Cited by 1,660
Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity
Calabrese, V., Mancuso, C., Calvani, M., Rizzarelli, E., Butterfield, D. A., & Giuffrida Stella, A. M. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2214 · Cited by 1,543 · cited 12×
“Heat shock proteins (Hsps), such as heme oxygenase-1, Hsp72, as well as sirtuins and thioredoxin/thioredoxin reductase, are all active vitagenes (Balch et al., 2008; Calabrese et al., 2007b).”
BackgroundInfluentialSelf-citationMolecular mechanisms regulating NLRP3 inflammasome activation
Jo, E.-K., Kim, J. K., Shin, D.-M., & Sasakawa, C. (2016) · Cellular & Molecular Immunology · doi:10.1038/cmi.2015.95 · Cited by 1,378 · cited 1×
“Caspase-1 cleavage of proIL-1b and proIL-18, and consequent secretion of mature inflammatory cytokines, induce pyroptosis, which is mechanistically and morphologically distinct from apoptosis (Jo et al., 2016).”
BackgroundDiniz, B. S., Butters, M. A., Albert, S. M., Dew, M. A., & Reynolds, C. F. (2013) · British Journal of Psychiatry · doi:10.1192/bjp.bp.112.118307 · Cited by 1,290
Transcriptional regulatory circuits controlling mitochondrial biogenesis and function
Kelly, D. P., & Scarpulla, R. C. (2004) · Genes & Development · doi:10.1101/gad.1177604 · Cited by 1,243
The sites and topology of mitochondrial superoxide production
Brand, M. D. (2010) · Experimental Gerontology · doi:10.1016/j.exger.2010.01.003 · Cited by 1,217 · cited 1×
“There are eight sites in mitochondria that are known to possess the ability to produce O2 2 (Druzhyna et al., 2008; Brand, 2010; Calabrese et al., 2010).”
BackgroundCerebral microvascular pathology in aging and Alzheimer's disease
Farkas, E., & Luiten, P. G. M. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00068-x · Cited by 1,102
Proteotoxic stress and inducible chaperone networks in neurodegenerative disease and aging
Morimoto, R. I. (2008) · Genes & Development · doi:10.1101/gad.1657108 · Cited by 872
Bioenergetic role of mitochondrial fusion and fission
Westermann, B. (2012) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2012.02.033 · Cited by 687
Solomon, A., Kivipelto, M., Wolozin, B., Zhou, J., & Whitmer, R. A. (2009) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000231980 · Cited by 557
Statins for the prevention of dementia
McGuinness, B., Craig, D., Bullock, R., & Passmore, P. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003160.pub3 · Cited by 490
Cerebral Amyloid Angiopathy: Emerging Concepts
Yamada, M. (2015) · Journal of Stroke · doi:10.5853/jos.2015.17.1.17 · Cited by 367 · cited 2×
“, accumulation of Ab in the walls of arteries and arterioles in the meninges and cortex (Yamada, 2015).”
BackgroundDaiber, A. (2010) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2010.01.032 · Cited by 347
Calabrese, V., Scapagnini, G., Giuffrida Stella, A. M., Bates, T. E., & Clark, J. B. (2001) · Neurochemical Research · doi:10.1023/a:1010955807739 · Cited by 263 · cited 2×
“Such insult leads to formation of toxic aldehydes, including 4- hydroxynonenal and acrolein, which are contributory to the pathogenesis of oxidative damage in a variety of neuropathological conditions (Calabrese et al., 2000, 2001, 2009).”
BackgroundSelf-citationCardiovascular risk factors and dementia
Fillit, H., Nash, D. T., Rundek, T., & Zuckerman, A. (2008) · The American Journal of Geriatric Pharmacotherapy · doi:10.1016/j.amjopharm.2008.06.004 · Cited by 225
Nitric Oxide Synthase Activity Is Elevated in Brain Microvessels in Alzheimer′s Disease
Dorheim, M. A., Tracey, W. R., Pollock, J. S., & Grammas, P. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.2716 · Cited by 216
Li, A., Zhang, S., Li, J., Liu, K., Huang, F., & Liu, B. (2016) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.06.008 · Cited by 197 · cited 1×
“Pathogen-associated molecular patterns (PAMPs), which are highly conserved among various microbial species, are critical activators of proinflammatory responses (Li et al., 2016).”
BackgroundCholesterol as a causative factor in Alzheimer's disease: a debatable hypothesis
Wood, W. G., Li, L., Müller, W. E., & Eckert, G. P. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12637 · Cited by 194 · cited 1×
“Preclinical data demonstrated that simvastatin restored vascular reactivity and endothelial function and reduced string vessel pathology in a mouse model of cerebrovascular disease (Wood et al., 2014a; Wood et al., 2014b; Tong et al., 2015).”
BackgroundSelf-citationCalabrese, E. J. (2008) · Ageing Research Reviews · doi:10.1016/j.arr.2007.07.001 · Cited by 180
Self-citationVascular Risk Factors and Dementia: 40-Year Follow-Up of a Population-Based Cohort
Rönnemaa, E., Zethelius, B., Lannfelt, L., & Kilander, L. (2011) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000330020 · Cited by 171 · cited 1×
“Vascular risk factors influence the future risk of dementia, particularly VaD (Ronnemaa et al., 2011).”
BackgroundEndothelial nitric oxide deficiency promotes Alzheimer’s disease pathology
Austin, S. A., Santhanam, A. V., Hinton, D. J., Choi, D., & Katusic, Z. S. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12334 · Cited by 155 · cited 2×
“Furthermore, endothelial NO production can be compromised by the interactive effects of inflammation and chronic hypoperfusion, resulting in exacerbation of neurodegenerative processes characteristic of VaD (Calabrese et al., 2009; Austin et al., 2013).”
BackgroundAssociation of ideal cardiovascular health with vascular brain injury and incident dementia
Pase, M. P., Beiser, A., Enserro, D., Xanthakis, V., Aparicio, H., Satizabal, C. L., Himali, J. J., Kase, C. S., Vasan, R. S., DeCarli, C., et al. (2016) · Stroke · doi:10.1161/strokeaha.115.012608 · Cited by 137 · cited 1×
“Additionally, lifestyle factors such as nonsmoking, ideal body mass index, regular physical activity, and healthy diet, as well as optimum blood pressure, cholesterol, and fasting blood glucose, may protect against VaD (see Table I) (Pase et al., 2016).”
BackgroundRiba‐Llena, I., Nafría, C., Mundet, X., López‐Rueda, A., Fernández‐Cortiñas, I., Jarca, C. I., Jiménez‐Balado, J., Domingo, M., Tovar, J. L., Orfila, F., et al. (2016) · European Journal of Neurology · doi:10.1111/ene.12979 · Cited by 25
Cited by
Antioxidant Defence Systems and Oxidative Stress in Poultry Biology: An Update
Surai, P. F., Kochish, I. I., Fisinin, V. I., & Kidd, M. T. (2019) · Antioxidants · doi:10.3390/antiox8070235 · Cited by 655
Cao, X., Ding, L., Xie, Z.-Z., Yang, Y., Whiteman, M., Moore, P. K., & Bian, J.-S. (2019) · Antioxidants & Redox Signaling · doi:10.1089/ars.2017.7058 · Cited by 408
Inflammasomes, hormesis, and antioxidants in neuroinflammation: Role of NRLP3 in Alzheimer disease
Pennisi, M., Crupi, R., Di Paola, R., Ontario, M. L., Bella, R., Calabrese, E. J., Crea, R., Cuzzocrea, S., & Calabrese, V. (2017) · Journal of Neuroscience Research · doi:10.1002/jnr.23986 · Cited by 157
Zhang, M., Jia, J., Yang, Y., Zhang, L., & Wang, X. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102116 · Cited by 157
“Additionally, there is increasing evidence that oxidative stress contributes to the pathogenesis and progression of neurodegenerative diseases, such as Parkinson ’ s disease and vascular dementia (Calabrese et al., 2016; Mancuso et al., 2008).”
BackgroundChlorinative Stress in Age-Related Diseases: A Literature Review
Casciaro, M., Di Salvo, E., Pace, E., Ventura-Spagnolo, E., Navarra, M., & Gangemi, S. (2017) · Immunity & Ageing · doi:10.1186/s12979-017-0104-5 · Cited by 85
“Vitagens have also been studied in diseases typical of the old age such as neurodegenerative ones [11].”
Metadata
- Authors
- Calabrese, V., Giordano, J., Signorile, A., Laura Ontario, M., Castorina, S., De Pasquale, C., Eckert, G., & Calabrese, E. J.
- Venue
- Journal of Neuroscience Research
- Publisher
- Wiley
- Published
- 2016-09-23
- Volume
- 94
- Issue
- 12
- Pages
- 1588-1603
- ISSN
- 0360-4012 (ISSN-L)
- 1097-4547
- OpenAlex
- W2482353975
- Cited by
- 157
- References
- 30
- FWCI
- 7.87
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.